These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2882367)

  • 1. Dopamine receptor asymmetry in schizophrenia.
    Reynolds GP; Czudek C; Bzowej N; Seeman P
    Lancet; 1987 Apr; 1(8539):979. PubMed ID: 2882367
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine receptors in schizophrenia.
    Gjedde A; Reith J; Wong D
    Lancet; 1995 Nov; 346(8985):1302-3. PubMed ID: 7475750
    [No Abstract]   [Full Text] [Related]  

  • 3. Bimodal distribution of dopamine receptor densities in brains of schizophrenics.
    Seeman P; Ulpian C; Bergeron C; Riederer P; Jellinger K; Gabriel E; Reynolds GP; Tourtellotte WW
    Science; 1984 Aug; 225(4663):728-31. PubMed ID: 6147018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain dopamine receptor densities in schizophrenics.
    Iversen LL; Mackay AV
    Lancet; 1981 Jul; 2(8238):149. PubMed ID: 6113506
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine receptors in post-mortem schizophrenic brains.
    Reynolds GP
    Lancet; 1981 Jun; 1(8232):1261. PubMed ID: 6112585
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative determination of D2 dopamine receptor characteristics in healthy human subjects and psychiatric patients.
    Sedvall G; Farde L; Wiesel FA
    Life Sci; 1987 Aug; 41(7):813-6. PubMed ID: 2956473
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine D2 receptors in schizophrenia studied in vivo.
    Crawley JC; Owens DG; Crow TJ; Poulter M; Johnstone EC; Smith T; Oldland SR; Veall N; Owen F; Zanelli GD
    Lancet; 1986 Jul; 2(8500):224-5. PubMed ID: 2873471
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased dopamine-receptor sensitivity in schizophrenia.
    Owen F; Cross AJ; Crow TJ; Longden A; Poulter M; Riley GJ
    Lancet; 1978 Jul; 2(8083):223-6. PubMed ID: 79025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain.
    Mjörndal T; Winblad B
    Med Biol; 1986; 64(6):351-4. PubMed ID: 2881030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptors in schizophrenia.
    Sedvall G; Farde L
    Lancet; 1996 Jan; 347(8996):264. PubMed ID: 8551909
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder.
    Cross AJ; Crow TJ; Ferrier IN; Johnstone EC; McCreadie RM; Owen F; Owens DG; Poulter M
    J Neural Transm Suppl; 1983; 18():265-72. PubMed ID: 6135745
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine receptors in post-mortem schizophrenic brains.
    Seeman P
    Lancet; 1981 May; 1(8229):1103. PubMed ID: 6112469
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine receptors and transporters in Parkinson's disease and schizophrenia.
    Seeman P; Niznik HB
    FASEB J; 1990 Jul; 4(10):2737-44. PubMed ID: 2197154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of radioligands in schizophrenia research.
    Sedvall G; Farde L; Hall H; Halldin C; Karlsson P; Nordström AL; Nyberg S; Pauli S
    Clin Neurosci; 1995; 3(2):112-21. PubMed ID: 7583617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue.
    Reisine TD; Rossor M; Spokes E; Iversen LL; Yamamura HI
    Adv Biochem Psychopharmacol; 1980; 21():443-50. PubMed ID: 6246753
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.
    Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL
    Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cerebral dopamine metabolism and receptors during one-year neuroleptic administration and subsequent withdrawal: relevance to brain biochemistry in schizophrenia.
    Clow A; Jenner P; Theodorou A; Marsden CD
    Adv Biochem Psychopharmacol; 1980; 24():53-5. PubMed ID: 6105799
    [No Abstract]   [Full Text] [Related]  

  • 19. Endorphins, dopamine, and schizophrenia.
    Volavka J; Davis LG; Ehrlich YH
    Schizophr Bull; 1979; 5(2):227-39. PubMed ID: 37595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor supersensitivity and schizophrenia: a review.
    Langer DH; Brown GL; Docherty JP
    Schizophr Bull; 1981; 7(2):208-24. PubMed ID: 7025187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.